Concepedia

Publication | Open Access

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study

DOIFull Paper Access

21

Citations

34

References

2012

Year

Namiki Izumi, Yasuhiro Asahina, Masayuki Kurosaki, Gotaro Yamada, Tsutomu Kawai, Eiji Kajiwara, Yukishige Okamura, Takayuki Takeuchi, Osamu Yokosuka, Kazuya Kariyama,
Journal of Gastroenterology

Abstract

Low-dose and long-term maintenance administration of PegIFNα-2a decreased the incidence of HCC in patients with normalized ALT and AFP levels at 24 weeks compared with patients without normal ALT and AFP levels.

References

YearCitations

Page 1